SCHEMBL2923540

SCHEMBL2923540

CCOP(=O)(OCC)[C@](C)(NC(=O)OC(C)(C)C)C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.38
PTPRB P23467 1/20 0.36
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA14 Q9ULX7 2/20 0.33
CA7 P43166 2/20 0.33
TDP1 Q9NUW8 1/20 0.32
MAPT P10636 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
KMT2A Q03164 1/20 0.30
CA9 Q16790 1/20 0.30
CTSS P25774 1/20 0.30
CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1111032 0.86 CTSK (0.36) CA12CA1CA2CA14CA7
SCHEMBL7674935 0.73 DGAT1 (0.43) DGAT1CA12CA1CA2HTT
SCHEMBL11143316 0.71 PPARD (0.34) DGAT1CA12CA1CA2TDP1
SCHEMBL14819108 0.71 CA1 (0.39) CA12CA1CA2CA14CA7
SCHEMBL1852632 0.70 MEN1 (0.37) DGAT1CA12CA1CA2CA14
SCHEMBL28682014 0.69 DGAT1 (0.45) DGAT1PTPRBCA12CA1CA2
SCHEMBL29383045 0.69 DGAT1 (0.45) DGAT1PTPRBCA12CA1CA2
SCHEMBL4792294 0.69 DGAT1 (0.45) DGAT1PTPRBCA12CA1CA2
SCHEMBL28682013 0.69 DGAT1 (0.45) DGAT1PTPRBCA12CA1CA2
SCHEMBL88463 0.69 DGAT1 (0.45) DGAT1PTPRBCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225253-A1 PHOSPHONIC ACID DERIVATES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-09-08 EP disclosed
WO-2009069100-A1 PHOSPHONIC ACID DERIVATES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-06-04 WO disclosed